news roundup
Through its partnership with the National Biomedical Research Ethics Council, Schulman developed its Central Neurology Review (CNR) service to assist research institutions and biopharma and device companies in navigating the latest developments in neurology research and human subject protections.
| advertisment
Clinical Trial Simulation: An Efficient Tool for Improved Study Designs, Dose Selection and Go/No-go Investment Decisions
Live Webcast: Tuesday, September 19 at 2:00pm BST and Thursday, September 28 at 10am EDT
 Register now |
Başkent University, a hospital cluster headquarters in Ankara, Turkey, is joining Clinerion's Patient Recruitment System platform, giving its 4.5 million patients access to treatments and therapies offered by clinical research.
| advertisment
A New Paradigm: Cutting-edge Processes and Analytics in Site and Patient Selection
On Demand
 Learn more |
CRO Clinipace Worldwide has launched a new regulatory and strategic development consultancy called RSD Global Consulting (RSDGC). RSDGC offers strategic consulting and regulatory support in the U.S., Europe, and Asia Pacific.
TrialScope's newest solution, Core Disclosure, allows teams to approve disclosure content one time and then reuse the disclosure data globally.
|
|
|
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
Articles
As the growth in rare disease studies increase, experts say they require a different approach to clinical trials, as well as highly motivated and skilled CRAs to carry it out.
When recording ECGs in the clinic it is of the utmost importance to collect tracings of the best possible quality since signals with noise and artefact might have the appearance of atrial fibrillation and will be diagnosed as such by the ECG machines.
|
|
|
Blog Posts
A panel of experienced patient advocates and disease group leaders will discuss patient concerns about clinical trial design and conduct involving medical devices at its inaugural meeting on October 11-12, 2017.
Through the network, community practices can select the types of research in which they would like to participate and provide access to key patient information to facilitate patient identification. Clinical researchers can then leverage the AdvanceIQ Network to find practices treating patients who meet specific trial criteria.
|
|
|
Oncology
Although the value of minimal residual disease (MRD) measurement in oncology is well defined in clinical development, the best technical approach can be variable based on a number of factors. This free webcast from Q2 Solutions discusses MRD Measurement in depth.
Almac Diagnostics has announced its selection by the EORTC as a partner for the molecular profiling of cancer patient samples from their clinical trial data and that of pan-European Cancer network, SPECTA.
The challenges in defining clinical endpoints presented by the mechanism of action of immunotherapeutic agents differentially affects early and late phase studies.
|
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
|
